Polycythemia vera overview: Difference between revisions
Jump to navigation
Jump to search
Created page with "{{CMG}} {{Polycythemia vera}} ==Overview== '''Primary polycythemia''', often called '''polycythemia vera''' (PCV), polycythemia rubra vera (PRV), or erythremia, occur..." |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Polycythemia vera}} | |||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
'''Primary [[polycythemia]]''', often called '''[[polycythemia vera]]''' (PCV), polycythemia rubra vera (PRV), or erythremia, occurs when excess red blood cells are produced as a result of an abnormality of the [[bone marrow]]. Often, excess [[white blood cell]]s and [[platelet]]s are also produced. Polycythemia vera is classified as a [[myeloproliferative disease]]. | '''Primary [[polycythemia]]''', often called '''[[polycythemia vera]]''' (PCV), polycythemia rubra vera (PRV), or erythremia, occurs when excess red blood cells are produced as a result of an abnormality of the [[bone marrow]]. Often, excess [[white blood cell]]s and [[platelet]]s are also produced. Polycythemia vera is classified as a [[myeloproliferative disease]]. | ||
| Line 13: | Line 14: | ||
[[de:Polycythaemia vera]] | [[de:Polycythaemia vera]] | ||
[[Category:Disease]] | |||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
Revision as of 21:14, 12 September 2012
|
Polycythemia vera Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Polycythemia vera overview On the Web |
|
American Roentgen Ray Society Images of Polycythemia vera overview |
|
Risk calculators and risk factors for Polycythemia vera overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Primary polycythemia, often called polycythemia vera (PCV), polycythemia rubra vera (PRV), or erythremia, occurs when excess red blood cells are produced as a result of an abnormality of the bone marrow. Often, excess white blood cells and platelets are also produced. Polycythemia vera is classified as a myeloproliferative disease.